HEPATIC STEATOSIS IS INDEPENDENTLY ASSOCIATED WITH ERECTILE DYSFUNCTION: ONE MORE LINK BETWEEN THE LIVER AND CARDIOVASCULAR RISK?  by Laurinavicius, Antonio et al.
Vascular Medicine
A2125
JACC March 17, 2015
Volume 65, Issue 10S
hePatic SteatOSiS iS indePendently aSSOciated with erectile dySfunctiOn: One mOre 
link Between the liVer and cardiOVaScular riSk?
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Links Between Systemic and Vascular Diseases
Abstract Category: 45.  Vascular Medicine: Non Coronary Arterial Disease
Presentation Number: 1225-344
Authors: Antonio Laurinavicius, Raquel Conceicao, Viviane Arevalo Tabone, Raul Santos, Preventive Medicine Unit. Hospital Israelita 
Albert Einstein, Sao Paulo, Brazil, Instituto do Coração HCFMUSP, Sao Paulo, Brazil
Background:  Hepatic steatosis (HS), the hepatic hallmark of the metabolic syndrome, is associated with a higher risk of cardiovascular 
disease. Both clinical and subclinical atherosclerosis have been associated with the presence of HS, which has been regarded as a new 
emerging cardiovascular risk factor. Pathophysiological mechanisms include active secretion of cytokines by the steatotic liver promoting 
endothelial dysfunction. Erectile dysfunction (ED) predicts cardiovascular events beyond traditional risk factors and is tightly related to 
endothelial function. We studied the association between HS and ED.
methods:  We studied 9,655 consecutive and apparently healthy men over 40 years old (mean age: 48.9 years) who underwent a check-
up protocol between 2009 and 2013. All the participants were submitted to an extensive clinical and laboratory evaluation and completed 
the International Index of Erectile Function (IIEF-5) Questionnaire. HS was detected by abdominal ultrasonography. Alcohol intake was 
assessed by the AUDIT Score. The association between HS and ED was tested by multiple logistic regression.
results:  Prevalence of HS was 50.8%. Overall, ED was detected in 6.3% (n=609) of our study population (mild: 55.2%; mild to moderate: 
28.7%; moderate: 13%; severe: 3.1%). Individuals with HS showed a higher prevalence of ED than those without HS (7.7% vs. 4.9%, 
p<0.001). Subjects with ED were older (56.3 vs 48.4 y, p<0.001) and presented a higher burden of cardiovascular risk factors, including 
hypertension (p<0.001), diabetes (p<0.001), dyslipidemia (p<0.001), obesity (p<0.001) and physical inactivity (p=0.001). Smoking was not 
significantly associated with ED (p=0.916). HS remained a statistically significant predictor of ED (OR 1.25, 95% CI 1.02 to 1.53, p = 0.035) 
even after adjustment for age, alcohol intake, body mass index and the presence of the metabolic syndrome.
conclusion:  Hepatic steatosis is independently associated with erectile dysfunction. Putative mechanisms include systemic promotion of 
endothelial dysfunction by hepatic cytokines.
